Lymphoid cell infiltration during breast cancer growth: A syngeneic rat model

Immunology and Cell Biology

Volumn 76, Issue 6, 1998, Pages 550-555

  Zhang, Xu Dong ^a   Schiller, Grant David ^a   Gill, Peter Grantly ^a   Coventry, Brendon John ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Breast cancer; Immunohistochemistry; Lymphoid cells; Syngeneic rat model

Indexed keywords

CD24 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER GROWTH; CELL INFILTRATION; CELL SUBPOPULATION; CLONAL ANERGY; DENDRITIC CELL; FEMALE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE ACTIVATION; LYMPHOID CELL; MACROPHAGE; NONHUMAN; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE;

ADENOCARCINOMA; ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; LYMPHOCYTES, TUMOR-INFILTRATING; MACROPHAGES; MAMMARY NEOPLASMS, EXPERIMENTAL; RATS; RECEPTORS, INTERLEUKIN-2; TIME FACTORS; TRANSPLANTATION, ISOGENEIC;

AGOUTI; ANIMALIA;

EID: 0345561585     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1998.00780.x     Document Type: Article

References (21)

1. Underwood JCL. Lymphoreticular infiltration in human tumours: Prognostic and biological implications: A review. Br. J. Cancer 1974; 30: 538-48.
2. Black MM, Barclay TH, Hankey BF. Prognosis in breast cancer utilizing histologic characteristics of the primary tumor. Cancer 1975; 36: 2048-55.
3. Coventry BJ. Characterisation of tumour infiltrating lymphocytes in human solid tumours. PhD thesis. Flinders University of South Australia, Australia. 1991.
4. Coventry BJ, Weeks SC, Heckford SE, Sykes PJ, Bradley J, Skinner JM. Lack of IL-2 cytokine expression despite IL-2 messenger RNA transcription in tumor-infiltrating lymphocytes in primary human breast carcinoma: Selective expression of early activation markers. J. Immunol. 1996; 156: 3486-92.
5. Miescher S, Whiteside TL, Carrel S, von Fliedner V. Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: Effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J. Immunol. 1986; 136: 1899-907.
6. Garrido F, Cabrera T, Concha A, Glew S, Ruiz-Cabello F, Stern PL. Natural history of HLA expression during tumour development. Immunol. Today 1993; 14: 491-9.
7. Gabrilovich DI, Ciernik IF, Carbone DP. Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts. Cell. Immunol. 1996; 170: 101-10.
8. Tada T, Ohzeki S, Utsumi K et al. Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state. J. Immunol. 1991; 146: 1077-82.
9. Nilsson TM, Woods AE, Rofe AM. In vivo studies of macrophages and intercellular adhesion molecule-1 following lipopolysaccharide treatment in tumour-bearing rats. Immunol. Cell Biol. 1996; 74: 408-12.
10. Coventry BJ, Bradley J, Skinner JM. Differences between standard and high-sensitivity immunohistology in tissue sections: Comparison of immunoperoxidase staining methods using computerized video image analysis techniques. Pathology 1995; 27: 221-3.
11. Coventry BJ, Neoh SH, Mantzioris BX, Skinner JM, Zola H, Bradley J. A comparison of the sensitivity of immunoperoxidase staining methods with high-sensitivity fluorescence flow cytometry-antibody quantitation on the cell surface. J. Histochem. Cytochem. 1994; 42: 1143-7.
12. Martin MS, Caignard A, Hammann A, Pelletier H, Martin F. An immunohistological study of cells infiltrating progressive and regressive tumors induced by two variant subpopulations of a rat colon cancer cell line. Int. J. Cancer 1987; 40: 87-93.
13. Frey AB. Study of immune response to tumors in the rat. Methods 1997; 12: 173-88.
14. Bal V, McIndoe A, Denton G et al. Antigen presentation by keratinocytes induces tolerance in human T cells. Eur. J. Immunol. 1990; 20: 1893-7.
15. Russell SW, Gillespie GY, Pace JL. Evidence for mononucleur phagocytes in solid neoplasms and appraisal of their nonspecific cytotoxic capabilities. Contemp. Top. Immunobiol. 1980; 10: 143-66.
16. Talmadge JE, Key M, Fidler IJ. Macrophage content of metastatic and nonmetastatic rodent neoplasms. J. Immunol. 1981; 126: 2245-8.
17. Seljelid R, Busund LT. The biology of macrophages. II. Inflammation and tumors. Eur. J. Haematol. 1994; 52: 1-12.
18. Chaux P, Hammann A, Martin F, Martin M. Surface phenotype and functions of tumor-infiltrating dendritic cells: CD8 expression by a cell subpopulation. Eur. J. Immunol. 1993; 23: 2517-25.
19. Kradin RL, Xia W, Pike M, Byers HR, Pinto C. Interleukin-2 promotes the motility of dendritic cells and their accumulation in lung and skin. Pathobiology 1996; 64: 180-6.
20. An T, Sood U, Pietruk T, Cummings G, Hashimoto K, Crissman JD. In situ quantitation of inflammatory mononuclear cells in ductal infiltrating breast carcinoma. Relation to prognostic parameters. Am. J. Pathol. 1987; 128: 52-60.
21. Chesnut RW, Grey HM. Antigen presentation by B cells and its significance in T-B interactions. Adv. Immunol. 1986; 39: 51-94.